Answer
Yes, secondary causes of hyperlipidaemia should be adequately treated before fenofibrate therapy is considered, and when medicines may be responsible, it should be established whether the hyperlipidaemia is primary or secondary.
Sources for this answer
- Lipantil Micro 67Viatris (formerly Mylan or Upjohn) · emc · SmPC §4.4 Special warnings and precautions for use · Version 30Document updated
Sources checked